McKesson is trading 4.48% up at $1,057.65, with no clear company-specific catalyst identified for the October 23 pre-market move.

  • Latest company-specific coverage points to the CVS distribution partnership extension announced October 1, not a fresh overnight announcement.
  • McKesson’s October 22 hero-news report also described a pre-market gain without a clear company catalyst.
  • Broader-market signals are mixed and do not clearly explain the move; its immediate reason remains uncertain.